Search for: "Abbott Laboratories, Inc"
Results 301 - 320
of 448
Sorted by Relevance
|
Sort by Date
14 May 2010, 11:27 am
Cir. 2005); Abbott Labs. v. [read post]
4 Jun 2011, 5:13 pm
Abbott Laboratories, Inc. [read post]
3 Jul 2008, 7:26 pm
Abbott Laboratories, 568 F. [read post]
15 Mar 2007, 6:33 am
Abbott Laboratories, Inc., 2006 WL 3457617, *12 (D. [read post]
12 May 2022, 6:02 am
’ ” Abbott Laboratories v. [read post]
24 Nov 2010, 8:22 am
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
24 Nov 2010, 8:22 am
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
19 Aug 2010, 3:00 am
Abbott Laboratories (E.D. [read post]
17 Sep 2009, 4:30 am
McNeil Laboratories, Inc., 807 F.2d 464 (5th Cir. 1987). [read post]
17 Oct 2013, 5:00 am
Medtronic, Inc., 238 F. [read post]
24 Aug 2015, 5:00 am
Abbott Laboratories, Inc., ___ F. [read post]
24 Jan 2020, 10:24 am
Walgreens – In January 2019, Walgreens Boots Alliance, Inc. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
25 May 2009, 5:20 pm
(The IP Factor) Israel Patent Office practice regarding legal expenses in oppositions (The IP Factor) New Zealand New Zealand launches second ACTA consultation (Michael Geist) United Kingdom EWHC request for summary judgment denied - OHIM-IPO class heading conflict case: Daimler v Sany (IPKat) United States US General Trade secret litigation on the rise against laid off employees (Silicon Valley IP Licensing Law Blog) Seeking and justifying attorney fee awards may be… [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
5 May 2010, 10:14 pm
Cir. 2006), and Paragon Podiatry Laboratory, Inc. v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
30 Jan 2020, 10:49 am
Abbott Labs – Multistate – $25 million. [read post]
29 May 2009, 6:32 am
See McCall, Abbott, AIG, Ryan v. [read post]
9 May 2012, 11:09 am
Co-authored by Richard Alfred and Jessica Schauer The Seventh Circuit ruled yesterday that pharmaceutical sales representatives (“PSRs”) for Eli Lilly & Co. and Abbott Laboratories Inc. are exempt from overtime under the Fair Labor Standards Act (“FLSA”) under the Administrative Exemption. [read post]